Application 203246
- Type
- ANDA
- Sponsor
- UNIV TX MD ANDERSON
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | FLUDEOXYGLUCOSE F18 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | 20-150mCi/ML | No | No |
| 002 | FLUDEOXYGLUCOSE F18 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | 20-300mCi/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 60215-411 | Fludeoxyglucose | Fludeoxyglucose F18 | The University of Texas MD Anderson Cancer Center | ANDA | Current |
| 60215-411 | Fludeoxyglucose | Fludeoxyglucose F18 | The University of Texas MD Anderson Cancer Center | ANDA | Current |
| 60215-411 | Fludeoxyglucose | Fludeoxyglucose F18 | The University of Texas MD Anderson Cancer Center | ANDA | Current |